NCT06837987View on ClinicalTrials.gov

Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

August 1, 2025

Conditions
Aplastic AnaemiaTransplantation Conditioning
Interventions
OTHER

Modified transplantation system

Modified transplantation conditioning include: Fludarabine 30mg/m2\*6 day, Melphalan 100mg/m2\*1 day, cyclophosphamide 50mg/kg\*2 day.

Trial Locations (1)

650000

Department of Hematology，920th Hospital of Joint Logistics Support Force, Kunming

All Listed Sponsors
lead

Hematology department of the 920th hospital

OTHER

NCT06837987 - Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT. | Biotech Hunter | Biotech Hunter